Nasdaq FB FaceBook

Super Micro Computer (NASDAQ: SMCI) might not be a household name, but the computing hardware stock has been one of the biggest winners thus far in the artificial intelligence (AI) boom.

Investors looking for the next winning stock should look at historical winners. This could result in identifying unique insights that have helped contribute to a company's success, which can be applied when searching for businesses to buy.

Social Security benefits are protected from inflation by annual cost-of-living adjustments (COLAs). But some retired workers feel shortchanged by the 3.2% COLA in 2024. That figure is paltry when compared to the 8.7% boost in 2023 and the 5.9% COLA in 2022, and the rampant inflat

Most people love the idea of buying an outstanding stock and holding it forever -- one great decision that builds wealth for you for decades without any additional action needed. But the reality is that finding individual stocks capable of such hands-free maintenance is extremely

Last year was a fantastic one for the market with the S&P 500 jumping 24% after dropping by double digits in 2022. A lot of businesses benefited from the ongoing rally.

Shares in Whirlpool (NYSE: WHR) declined 10.1% in January, according to data provided by S&P Global Market Intelligence. The down move in January follows a double-digit gain in December. The volatility in its share price reflects the market's sentiment toward interest rate-sensit

You might think spending more on a vehicle means fewer hassles and headaches. After all, doesn't a high price tag equate to a higher-quality design and streamlined mechanics that will keep your car on...

If you plan to deposit $10,000 or more into your checking account, there are a few things you should consider first. By law, banks have to report deposits that exceed a certain amount. Best Bank...

If you're not someone who has inherited major family assets, becoming rich can seem like a major challenge, or even the challenge of a lifetime. This is especially true for younger Americans who are...

Warren Buffett, one of the most successful investors in the world, has a reputation for his simple yet profound financial wisdom. Warren Buffett's Financial Plan to Tackle America's Debt: 'I Can End...

By most measures, investors have reason to be skeptical about vaccine specialist Novavax ( NASDAQ:NVAX ). Once heralded as a key player in the race to find a solution for the COVID-19 disaster, Novavax shares collapsed as fears of the virus faded sharply. Since then, the company has struggled for relevance. While very few experts will see the biotechnology firm as a robust investment opportunity, too much bad news could fuel a shocking reversal. Therefore, I am near-term bullish on NVAX stock. Skepticism Reigns Supreme for NVAX Stock Before diving into the factors that could spark a rally that few believe possible, it’s important to acknowledge the deep-seated troubles Novavax faces. For example, even with the promise of a new year, NVAX stock fell by a staggering 20% since the beginning of January. And just to reinforce the point, in the past 52 weeks, NVAX had shed about 66% of its equity value. If stakeholders were hoping for an auspicious start, this wasn’t it. Further, management itself isn’t giving off encouraging signals. As the TipRanks Newsdesk pointed out recently, Novavax announced a strategic plan to reduce its annual spending. That’s the fancy way of saying it will lay off its global workforce. Unfortunately, the job cuts will impact approximately 12% of the firm’s full-time employees and contractors. Moreover, it wasn’t the first time Novavax resorted to a headcount reduction. In May 2023, management made the decision to cut 25% of its workforce. While the move should theoretically help streamline its financials, the main issue has always been scientific relevancy. According to The New York Times, Novavax was on the verge of collapse a year before the COVID-19 crisis. “One of its leading vaccine candidates — to prevent a deadly virus in infants — had failed for the second time in three years. The company’s stock was trading so low that it risked being removed from the Nasdaq,” the NYT wrote. Then, the pandemic gave NVAX stock a second lease on life. Certainly, it made the most of its opportunity. On a weekly average basis, NVAX briefly breached the $290 level. However, since December 2021, Novavax has been struggling to gain traction. Essentially, the company is almost back to where it once was. With the COVID catalyst all but gone, management must convince its remaining shareholders to hold true. That’s a gargantuan task. However, NVAX stock may still get its lifeline. Why Betting Against Novavax Is a Bad Idea Given the terrible print, traders may be tempted to bet against NVAX stock. That might be a bad idea. Like a sports wager, if the bookie sweetens the pot with line adjustments that increasingly favor the underdog, at some point, betting on the favorite could be a risky venture. And that may be the case with Novavax. Unsurprisingly, an options flow screener – which exclusively filters for big block transactions likely made by institutions – shows heavy volume of short (sold) calls. Basically, these are bets that the underlying security will not rise above a specified strike price. In particular, on January 16, a trader (or traders) sold 7,355 contracts of the NVAX Apr 19 ’24 5.00 Call. Additionally, it’s a high-conviction trade. For underwriting the risk, the call sellers received a premium of $371,000. However, at the money, the baseline totality of this trade is worth about $3.68 million (7,355 contracts multiplied by 100 shares per contract multiplied by the $5 strike). And the underlying liability is uncapped because NVAX stock could theoretically rise indefinitely. Now, many, if not most, traders likely believe that Novavax won’t rise materially higher; hence, the high short call volume. Still, because so many traders are standing on one side, the gamma exposure for the option arena’s market makers stands at $140,000 for every 1% stock move. In a bid to be “delta neutral,” the market maker would be forced to take opposite wagers should NVAX stock move unexpectedly. To quickly explain, in options trading, gamma exposure measures the rate of change in an option's delta concerning the underlying stock's price movement. To hedge against risk and maintain delta neutrality, market makers may need to adjust their options positions by taking counteractive measures. Such an unexpected move could very well occur because NVAX simultaneously runs an extremely high short interest of 48.24% of its float. Also, the short-interest ratio stands at 9.44 days to cover, requiring about two trading weeks for the bears to fully unwind their short position based on average trading volume. If NVAX stock swings higher for whatever reason, it could panic the shorts in the open market, which could easily cascade into panic in the options market as the sold calls get blown up. A Longer-Term Investment? No. While it’s critical to stress that NVAX stock could catch unsuspecting prospective bears off guard, such a framework centers on the nearer-term narrative. Should investors consider Novavax as a longer-term buy? In my view, no. It’s just too risky. Perhaps most glaringly, the company posted revenue of just under $187 million in the third quarter of Fiscal 2023. In sharp contrast, Novavax generated sales of $628.3 million in the year-ago period. Adding to the misery, without a clear product candidate, the biotech’s future is very much in question. Is NVAX Stock a Buy, According to Analysts? Turning to Wall Street, NVAX stock has a Hold consensus rating based on two Buys, one Hold, and one Sell rating. The average NVAX stock price target is $14.75, implying 275.3% upside potential. The Takeaway: NVAX Stock Offers a Temporary Opportunity Embattled Novavax could see a short-term rally due to heavy bearish bets. Despite facing significant challenges, including declining revenue and workforce reductions, the high short interest and concentrated short call positions leave NVAX stock vulnerable to a potential squeeze if the share price unexpectedly rises. However, this is not considered a long-term investment opportunity due to the company's uncertain future and lack of a clear product candidate. Disclosure

Continued growth in revenue and earnings, led by a robust product portfolio, could propel this AI stock more than 46% higher from current levels.

The United States launched a series of strikes against targets in Yemen on Saturday, three U.S. officials told Reuters, in what appeared to be a second day of major operations against Iran-linked targets following a deadly attack on American troops last weekend.

Viral videos of the Charging Bull bronze statue on Wall Street wearing a knitted hat sent commentators on X, formerly Twitter, into a frenzy and the referenced memecoin Dogwifhat (CRYPTO: WIF) surging 17%. What Happened: On Friday afternoon, videos ...

A car is a major investment, therefore you're probably going to want one that will last for as long as possible. While the average vehicle has only an 11.8% chance of lasting 250,000 miles, some cars...

Most opinion polls have shown that immigration has become a main election issue, and economist and Nobel Laureate Paul Krugman, on Friday, weighed on the merits of concerns around it. What Happened: “Immigration is looming larger in the campaign, ...

Cloud titans Amazon, Inc. (NASDAQ:AMZN), Microsoft Corp. (NASDAQ:MSFT) and Alphabet, Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) all reported fourth-quarter results this week, and the spotlight was on their Cloud businesses, given their high-margin nature. The ...

Part of the reason so many lottery winners and heirs blow their windfalls shortly after getting rich is that they never learned the skills to manage, guard and grow that kind of money. The other...

Having an open mind about brand reputation, space, performance, looks and even price is a great thing to carry when you're on the prowl for a used car, but having detailed reliability data from...

Below is Validea's guru fundamental report for APPLIED OPTOELECTRONICS INC (AAOI). Of the 22 guru strategies we follow, AAOI rates highest using our Quantitative Momentum Investor model based on the published strategy of Wesley Gray. This momentum model looks for stocks with str